BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4020836)

  • 1. Pilocarpic acid esters as novel sequentially labile pilocarpine prodrugs for improved ocular delivery.
    Bundgaard H; Falch E; Larsen C; Mosher GL; Mikkelson TJ
    J Med Chem; 1985 Aug; 28(8):979-81. PubMed ID: 4020836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of methylcellulose and carboxymethylcellulose on the biological availability of eye drops containing pilocarpine hydrochloride].
    Nerlo H; Wieluńska Z
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():67-71. PubMed ID: 7052782
    [No Abstract]   [Full Text] [Related]  

  • 3. Pilocarpine prodrugs. II. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters.
    Bundgaard H; Falch E; Larsen C; Mosher GL; Mikkelson TJ
    J Pharm Sci; 1986 Aug; 75(8):775-83. PubMed ID: 3772750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man.
    Saettone MF; Giannaccini B; Teneggi A; Savigni P; Tellini N
    J Pharm Pharmacol; 1982 Jul; 34(7):464-6. PubMed ID: 6126549
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume.
    Patton TF
    J Pharm Sci; 1977 Jul; 66(7):1058-9. PubMed ID: 886449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular penetration of pilocarpine: the effect of pH on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1975 Feb; 7(2):293-6. PubMed ID: 235874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of influence of rabbit nictitating membrane of miosis effect of pilocarpine.
    DeSantis LM; Schoenwald RD
    J Pharm Sci; 1978 Aug; 67(8):1189-90. PubMed ID: 671268
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged pulse-entry of pilocarpine with a soluble drug insert.
    Salminen L; Urtti A; Kujari H; Juslin M
    Graefes Arch Clin Exp Ophthalmol; 1983; 221(2):96-9. PubMed ID: 6654048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilocarpine prodrugs I. Synthesis, physicochemical properties and kinetics of lactonization of pilocarpic acid esters.
    Bundgaard H; Falch E; Larsen C; Mikkelson TJ
    J Pharm Sci; 1986 Jan; 75(1):36-43. PubMed ID: 3958903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric pseudolatices bearing pilocarpine for controlled ocular delivery.
    Vyas SP; Ramchandraiah S; Jain CP; Jain SK
    J Microencapsul; 1992; 9(3):347-55. PubMed ID: 1403485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the bioavallability of pilocarpine from its ophthalmic solutions.
    Soliman MM; El-Agizy HK; Elhofy OA; Salama HA; El Nimr AE; Khalil RM; Kassem MA
    Bull Ophthalmol Soc Egypt; 1978; 71(75):219-26. PubMed ID: 549717
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained release ophthalmic formulations of pilocarpine.
    Deshpande SG; Shirolkar S
    J Pharm Pharmacol; 1989 Mar; 41(3):197-200. PubMed ID: 2568450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pupillary response to four concentrations of pilocarpine in normal subjects: application to testing for Adie tonic pupil.
    Leavitt JA; Wayman LL; Hodge DO; Brubaker RF
    Am J Ophthalmol; 2002 Mar; 133(3):333-6. PubMed ID: 11860969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.
    Lee VH; Robinson JR
    J Pharm Sci; 1979 Jun; 68(6):673-84. PubMed ID: 458563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the cornea in the biologic response to pilocarpine.
    Van Hoose MC; Leaders FE
    Invest Ophthalmol; 1974 May; 13(5):377-83. PubMed ID: 4823178
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative determination of pilocarpine, isopilocarpine, pilocarpic acid, and isopilocarpic acid in clinical ophthalmic pilocarpine formulations by reversed-phase liquid chromatography.
    Noordam A; Maat L; Beyerman HC
    J Pharm Sci; 1981 Jan; 70(1):96-7. PubMed ID: 7229939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaceutical and clinical evaluation of soluble pilocarpine eye films].
    Maĭchuk IuF; Erichev VP
    Vestn Oftalmol; 1981; (2):48-50. PubMed ID: 7015673
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of oily vehicle on ocular pilocarpine concentration.
    Salminen L
    Acta Ophthalmol (Copenh); 1979 Aug; 57(4):633-6. PubMed ID: 525286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methylcellulose and ointment vehicles: their effects on ocular pharmacokinetics (author's transl)].
    Nagataki S; Sugaya M
    Nippon Ganka Gakkai Zasshi; 1978 Feb; 82(2):127-34. PubMed ID: 665445
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of physicochemical properties, stability in aqueous solutions and serum hydrolysis of pilocarpic acid diesters.
    Järvinen T; Suhonen P; Naumanen H; Urtti A; Peura P
    J Pharm Biomed Anal; 1991; 9(9):737-45. PubMed ID: 1821151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.